×
Entrez Id:
7015
Gene Symbol:
TERT
TERT
0.500
Biomarker
group
CTD_human
Genome-wide analysis of noncoding regulatory mutations in cancer.
25261935
2014
×
Entrez Id:
472
Gene Symbol:
ATM
ATM
0.500
Biomarker
group
CTD_human
Prenatal exposure to flavonoids: implication for cancer risk.
21177254
2011
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
0.500
Biomarker
group
CTD_human
Human ARF is implicated as a tumor suppressor gene, mainly in association with the simultaneous deletion of INK4A .
19223589
2009
×
Entrez Id:
672
Gene Symbol:
BRCA1
BRCA1
0.500
Therapeutic
group
CTD_human
Mutations of the breast cancer susceptibility gene 1 (BRCA1 ), a tumor suppressor, confer an increased risk for breast, ovarian, and prostate cancers.
15520196
2004
×
Entrez Id:
4609
Gene Symbol:
MYC
MYC
0.500
Biomarker
group
CTD_human
Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
11559025
2001
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
0.500
Biomarker
group
CTD_human
These data establish that p16Ink4a , along with p19Arf , functions as a tumour suppressor in mice.
11544531
2001
×
Entrez Id:
1436
Gene Symbol:
CSF1R
CSF1R
0.500
Biomarker
group
CTD_human
c-fms is present in primary tumours as well as in their metastases in bone marrow.
1390197
1992
×
Entrez Id:
1869
Gene Symbol:
E2F1
E2F1
0.400
Biomarker
group
CTD_human
Finally, we integrated this cooperative miRNA regulation into a more comprehensive network to account for E2F1 -related chemoresistance in tumour cells.
29464002
2018
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
0.400
Biomarker
group
CTD_human
In agreement with this hypothesis, CRISPR-mediated deletion of SNORD50A and SNORD50B in KRAS -mutant tumor cells enhanced tumorigenesis, and SNORD50A and SNORD50B deletion and oncogenic KRAS mutation co-occurred significantly in multiple human tumor types.
26595770
2016
APOBEC3B
0.400
Biomarker
group
CTD_human
An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
26258849
2015
×
Entrez Id:
2952
Gene Symbol:
GSTT1
GSTT1
0.400
Biomarker
group
CTD_human
Human health effects of dichloromethane: key findings and scientific issues.
25325283
2015
×
Entrez Id:
3757
Gene Symbol:
KCNH2
KCNH2
0.400
Biomarker
group
CTD_human
Allogeneic transplantation of hERG1 -expressing cells into nude mice resulted in an increased incidence of tumors .
24830940
2014
×
Entrez Id:
10232
Gene Symbol:
MSLN
MSLN
0.400
Biomarker
group
CTD_human
Individual predictors of increased serum mesothelin in asbestos-exposed workers.
23277285
2013
×
Entrez Id:
2067
Gene Symbol:
ERCC1
ERCC1
0.400
Biomarker
group
CTD_human
Excision repair of BPDE-adducts in human lymphocytes: diminished capacity associated with ERCC1 C8092A (rs3212986) polymorphism.
23203453
2013
×
Entrez Id:
3297
Gene Symbol:
HSF1
HSF1
0.400
Biomarker
group
CTD_human
Thus, cancers of many histologies exhibit activated HSF1 and increased HSP levels that may help to deter tumor suppression and evade therapy in the clinic.
22885793
2013
×
Entrez Id:
1386
Gene Symbol:
ATF2
ATF2
0.400
Biomarker
group
CTD_human
Oxidative stress and MAPK involved into ATF2 expression in immortalized human urothelial cells treated by arsenic.
23591579
2013
×
Entrez Id:
2740
Gene Symbol:
GLP1R
GLP1R
0.400
Biomarker
group
CTD_human
The effects of GLP-1 agonists on C-cell proliferation or neoplasia have not been documented in nonhuman primates or humans.
23471186
2013
×
Entrez Id:
3553
Gene Symbol:
IL1B
IL1B
0.400
Biomarker
group
CTD_human
Molecular characterization of a cancer-related single nucleotide polymorphism in the pro-inflammatory interleukin-1B gene.
22467534
2012
×
Entrez Id:
3606
Gene Symbol:
IL18
IL18
0.400
Therapeutic
group
CTD_human
Investigation of PEG-PLGA-PEG nanoparticles-based multipolyplexes for IL-18 gene delivery.
21273262
2012
×
Entrez Id:
7528
Gene Symbol:
YY1
YY1
0.400
Biomarker
group
CTD_human
Molecular characterization of a cancer-related single nucleotide polymorphism in the pro-inflammatory interleukin-1B gene.
22467534
2012
×
Entrez Id:
5329
Gene Symbol:
PLAUR
PLAUR
0.400
Biomarker
group
CTD_human
Nicotine stimulates urokinase-type plasminogen activator receptor expression and cell invasiveness through mitogen-activated protein kinase and reactive oxygen species signaling in ECV304 endothelial cells.
22261521
2012
×
Entrez Id:
196
Gene Symbol:
AHR
AHR
0.400
Biomarker
group
CTD_human
Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms.
22037238
2012
×
Entrez Id:
5243
Gene Symbol:
ABCB1
ABCB1
0.400
Biomarker
group
CTD_human
P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.
22269388
2012
×
Entrez Id:
7442
Gene Symbol:
TRPV1
TRPV1
0.400
Biomarker
group
CTD_human
However, we previously reported that the absence of TRPV1 in mice results in a striking increase in skin carcinogenesis, suggesting that chronic blockade of TRPV1 might increase the risk of tumor development.
21349818
2011
×
Entrez Id:
2878
Gene Symbol:
GPX3
GPX3
0.400
Biomarker
group
CTD_human
GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response.
21684681
2011